Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sunshine Biopharma (SBFM) Tax Provisions: 2022-2025

Historic Tax Provisions for Sunshine Biopharma (SBFM) over the last 3 years, with Sep 2025 value amounting to -$137,438.

  • Sunshine Biopharma's Tax Provisions fell 163.86% to -$137,438 in Q3 2025 from the same period last year, while for Sep 2025 it was -$515,502, marking a year-over-year decrease of 551.62%. This contributed to the annual value of -$234,858 for FY2024, which is 159.43% down from last year.
  • According to the latest figures from Q3 2025, Sunshine Biopharma's Tax Provisions is -$137,438, which was up 34.29% from -$209,166 recorded in Q2 2025.
  • In the past 5 years, Sunshine Biopharma's Tax Provisions ranged from a high of $233,304 in Q4 2022 and a low of -$343,691 during Q2 2024.
  • Its 3-year average for Tax Provisions is -$20,587, with a median of $22,353 in 2024.
  • Examining YoY changes over the last 5 years, Sunshine Biopharma's Tax Provisions showed a top increase of 425.53% in 2024 and a maximum decrease of 492.00% in 2024.
  • Quarterly analysis of 4 years shows Sunshine Biopharma's Tax Provisions stood at $233,304 in 2022, then dropped by 5.59% to $220,267 in 2023, then slumped by 158.45% to -$128,737 in 2024, then plummeted by 163.86% to -$137,438 in 2025.
  • Its Tax Provisions was -$137,438 in Q3 2025, compared to -$209,166 in Q2 2025 and -$40,161 in Q1 2025.